Jpmorgan Chase & CO Medtronic PLC Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Medtronic PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 52,195,764 shares of MDT stock, worth $5.03 Billion. This represents 0.33% of its overall portfolio holdings.
Number of Shares
52,195,764
Previous 52,195,764
-0.0%
Holding current value
$5.03 Billion
Previous $4.97 Billion
-0.0%
% of portfolio
0.33%
Previous 0.33%
Shares
21 transactions
Others Institutions Holding MDT
# of Institutions
2,505Shares Held
1.07BCall Options Held
9.42MPut Options Held
6.41M-
Vanguard Group Inc Valley Forge, PA127MShares$12.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.8 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.5MShares$5.82 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.7MShares$2.96 Billion0.57% of portfolio
-
Geode Capital Management, LLC Boston, MA27.6MShares$2.66 Billion0.17% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $128B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...